Our findings suggest that M-Se@SiO₂ have an immunomodulatory role in LPS-induced inflammation and bone remodeling, which demonstrates that M-Se@SiO₂ are a promising engineered nanoplatform for the treatment of osteolysis occurring after arthroplasty.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: